Vivos Therapeutics (VVOS) Non Operating Income (2022 - 2026)
Vivos Therapeutics (VVOS) reported Non Operating Income of -$1.2 million for Q1 2026, down 29075.0% year-over-year from N/an in Q1 2025, and down 84.94% quarter-over-quarter from -$631000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Non Operating Income (2022 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 5 years of Non Operating Income data on file, last reported at -$1.2 million in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$1.2 million, down 29075.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.6 million (down 2257.14% YoY), and the FY2025 annual result was -$1.5 million, down 1246.36% from the prior year.
- Non Operating Income declined to -$1.2 million in Q1 2026 per VVOS's latest filing, from -$631000.0 in the prior quarter.
- Over five years, Non Operating Income peaked at $51000.0 in Q1 2023 and troughed at -$1.2 million in Q1 2026.
- A 5-year average of -$184882.4 and a median of -$38000.0 in 2022 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2026: Non Operating Income surged 234.21% in 2023, then tumbled 29075.0% in 2026.
- A 5-year view of Non Operating Income shows it stood at -$38000.0 in 2022, then surged by 63.16% to -$14000.0 in 2023, then plunged by 385.71% to -$68000.0 in 2024, then tumbled by 827.94% to -$631000.0 in 2025, then slumped by 84.94% to -$1.2 million in 2026.
- Business Quant data shows VVOS's Non Operating Income at -$1.2 million in Q1 2026, -$631000.0 in Q4 2025, and -$679000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 159.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 62.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 121.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 61.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 71.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -55.03 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 14.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 36.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.80 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | -1.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -631,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Jun 30, 2023 | -225,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | -38,000.00 |